These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26438746)

  • 1. Out-Of-Pocket Prescription Costs Under A Typical Silver Plan Are Twice As High As They Are In The Average Employer Plan.
    Thorpe KE; Allen L; Joski P
    Health Aff (Millwood); 2015 Oct; 34(10):1695-703. PubMed ID: 26438746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Consumer Cost-Sharing for Health Plans Sold in the ACA's Insurance Marketplaces, 2015 to 2016.
    Gabel J; Green M; Call A; Whitmore H; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 May; 11():1-14. PubMed ID: 27214926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Will the Affordable Care Act's Cost-Sharing Reductions Affect Consumers' Out-of-Pocket Costs in 2016?
    Collins SR; Gunja M; Beutel S
    Issue Brief (Commonw Fund); 2016 Mar; 6():1-17. PubMed ID: 27017638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ACA’s Cost-Sharing Reduction Plans: A Key to Affordable Health Coverage for Millions of U.S. Workers.
    Gabel J; Whitmore H; Green M; Call A; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 Oct; 35():1-12. PubMed ID: 27827407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008-15.
    Moniz MH; Fendrick AM; Kolenic GE; Tilea A; Admon LK; Dalton VK
    Health Aff (Millwood); 2020 Jan; 39(1):18-23. PubMed ID: 31905056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the Value of Subsidies of Health Plans and Cost-Sharing for Prescription Drugs in the Health Insurance Marketplace.
    Ngorsuraches S; Mort JR
    Am Health Drug Benefits; 2016 Oct; 9(7):368-377. PubMed ID: 27994712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer Cost-Sharing in Marketplace vs. Employer Health Insurance Plans, 2015.
    Gabel J; Whitmore H; Green M; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2015 Dec; 38():1-11. PubMed ID: 26761957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating Premium and Out-of-Pocket Outlays Under All Child Dental Coverage Options in the Federally Facilitated Marketplace.
    Vujicic M; Yarbrough C
    J Pediatr; 2017 Mar; 182():349-355.e1. PubMed ID: 27989408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
    N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends underlying employer-sponsored health insurance growth for Americans younger than age sixty-five.
    Herrera CN; Gaynor M; Newman D; Town RJ; Parente ST
    Health Aff (Millwood); 2013 Oct; 32(10):1715-22. PubMed ID: 24101060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-deductible health plans.
    Committee on Child Health Financing
    Pediatrics; 2014 May; 133(5):e1461-70. PubMed ID: 24777210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.
    Yeung K; Barthold D; Dusetzina SB; Basu A
    N Engl J Med; 2020 Aug; 383(6):558-566. PubMed ID: 32757524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Specialty Medication Use for Common Chronic Inflammatory Diseases Among Health Exchange and Other Commercially Insured Members.
    Chen X; Gautam S; Ruggieri A; Richards T; Devries A; Sylwestrzak G
    J Manag Care Spec Pharm; 2018 Jan; 24(1):12-19. PubMed ID: 29290173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.